A 24-Year-Old Woman Presenting in the Third Trimester of Pregnancy with Nausea, Vomiting, and Abdominal Pain and Diagnosed with Acute Fatty Liver of Pregnancy
Issued Date
2022-01-01
Resource Type
eISSN
19415923
Scopus ID
2-s2.0-85136292476
Pubmed ID
35999773
Journal Title
American Journal of Case Reports
Volume
23
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Case Reports Vol.23 (2022)
Suggested Citation
Naothavorn W. A 24-Year-Old Woman Presenting in the Third Trimester of Pregnancy with Nausea, Vomiting, and Abdominal Pain and Diagnosed with Acute Fatty Liver of Pregnancy. American Journal of Case Reports Vol.23 (2022). doi:10.12659/AJCR.937085 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/87413
Title
A 24-Year-Old Woman Presenting in the Third Trimester of Pregnancy with Nausea, Vomiting, and Abdominal Pain and Diagnosed with Acute Fatty Liver of Pregnancy
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Patient: Female, 24-year-old Final Diagnosis: Acute fatty liver of pregnancy Symptoms: Abdominal pain Medication: — Clinical Procedure: Cesarean section Specialty: Gastroenterology and Hepatology • Obstetrics and Gynecology • Pediatrics and Neonatology Objective: Background: Case Report: Conclusions: Rare disease Acute fatty liver of pregnancy (AFLP) is a rare obstetric emergency that most commonly occurs in the third trimester and has high mortality rates for the mother and fetus. AFLP is a diagnosis of exclusion supported by identifying 6 or more of the 15 Swansea criteria. This report is of a 24-year-old woman presenting in the third trimester of pregnancy with nausea, vomiting, and abdominal pain and diagnosed with AFLP. A 24-year-old woman presented at 36 weeks of gestation with nausea, vomiting, and abdominal pain. Investigations showed leukocytosis, hyperbilirubinemia, increased liver enzymes, hypoglycemia, hyperurice-mia, acute kidney injury (AKI), and coagulopathy. Ten of the 15 Swansea criteria were fulfilled. An emergency cesarean section resulted in the delivery of a healthy infant, followed by a normalization of the mother’s liver function. Because long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency in the infant can be associated with maternal AFLP, genotyping of the infant was planned. This report has shown the importance of clinical awareness, rapid diagnosis, and management of AFLP. Screening for fetal LCHAD deficiency could help decrease mortality.